Australia markets close in 2 hours 53 minutes

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.2700-0.0450 (-3.42%)
As of 12:58PM AEST. Market open.
Currency in AUD

Valuation measures

Market cap (intra-day) 5515.72M
Enterprise value 3483.4M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)338.62
Price/book (mrq)7.38
Enterprise value/revenue 3317.40
Enterprise value/EBITDA 7-23.95

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 321.20%
S&P500 52-week change 331.83%
52-week high 32.5200
52-week low 31.0150
50-day moving average 31.4228
200-day moving average 31.7442

Share statistics

Avg vol (3-month) 3525.31k
Avg vol (10-day) 3794.68k
Shares outstanding 5406.08M
Implied shares outstanding 6N/A
Float 375.96M
% held by insiders 17.40%
% held by institutions 149.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 425 Mar 1988
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,343.66%

Management effectiveness

Return on assets (ttm)-20.52%
Return on equity (ttm)-35.69%

Income statement

Revenue (ttm)1.52M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-88.70%
Gross profit (ttm)5.67M
EBITDA -20.18M
Net income avi to common (ttm)-19.25M
Diluted EPS (ttm)-0.0510
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)70.27M
Total cash per share (mrq)0.17
Total debt (mrq)1.5M
Total debt/equity (mrq)2.15
Current ratio (mrq)10.30
Book value per share (mrq)0.17

Cash flow statement

Operating cash flow (ttm)-10.99M
Levered free cash flow (ttm)-5.87M